Ready to unravel the mysteries of advanced lipid profiles and their implications on cardiovascular health? We guarantee this episode will enhance your understanding, as we navigate through the complexities of lipoprotein-a, a genetic disorder affecting millions globally. Alongside notable cardiologist, Dr. Michael Koren and our esteemed guest, Albert Lopez, DO, we'll learn about the challenges in treating this genetic anomaly and the pivotal role that statins and different isoforms of Lp(a) play.

Ever wondered about the benefits of direct versus indirect LDL measurement in uncovering hidden risks for cardiovascular disease? Join us as we explore this fascinating topic. We'll express the importance of clinical trials, discuss the intriguing value of advanced lipid profiles, and delve into the implications of statin intolerance. Additionally, we'll discuss Lp(a), why screening younger individuals for it could be a game-changer in preventive care. Tune in to this enlightening discussion and equip yourself with crucial knowledge on lipid profiles and cardiovascular disease.

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

Have you ever wondered how Simon and Garfunkel's iconic song "Sound of Silence" became the hit we know today? Join us in this captivating episode as Kevin Geddings of WSOS Radio and Dr. Michael Koren, cardiologist and medical researcher, talk about Tom Wilson - a record producer who played a critical role in the Simon and Garfunkel's success. Discover how Wilson's keen eye for potential hits and his electrified versions of Simon and Garfunkel's songs skyrocketed their career, as well as the tragic story of Wilson's early death at the age of 47 due to a heart attack, believed to be caused by genetic dyslipidemia.

Dr. Koren also shares the importance of testing for Lp(a), a lipoprotein that isn't traditionally included in lab tests but can significantly impact an individual's risk of heart attack or stroke.  Get ready for a fascinating conversation that intertwines medical research, history, and the world of music!

Get tested for Lp(a)

Recording Date: June 26, 2023

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

In this captivating 6-minute MedEvidence Monday Minute, Dr. Koren and Kevin Geddings discuss routine lab work done for clinical trials that can discover and prevent silent health issues. Join us as we unravel the mysteries behind what your magnesium & Lp(a) lab values may indicate. Whether you're intrigued by the science or looking to enhance your well-being, this episode offers valuable knowledge to support a healthier mind and heart. Tune in and unlock the secrets of magnesium's potential in promoting brain and heart health.

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

MedEvidence! Radio is a monthly live broadcast from WSOS 103.9 FM / 1170 AM with Kevin Geddings and Dr. Michael Koren. This month's MedEvidence Radio discusses the Silent Killer, Lipoprotein(a), Diabetes, and Clinical Research Technologies.

We will dive into:
🩺Clinical Research
💙Lipoprotein(a)
🍬Diabetes
❤️Cardiovascular Health
🔬 Clinical Research Trials

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals.  Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.  On a personal note, Dr. Koren has a life-long interest in history, technology, Public Health, and music. He has written two musical plays.

More information and to Participate in Clinical Research 

Original Air Date: February 22, 2023

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

Continuing with Part 3 of Drs. Michael Koren and Dennis Leahy discussion on MedEvidence exploring Lipoprotein A treatments. Dr. Leahy shares his personal experience with Lp(a), and the duo delve into cutting-edge treatments and research. Tune in to learn more about this lesser known condition and possible treatment options.

Learn More:

• Nature Magazine, Targeting Lipoprotein(a) with siRNA
• Medscape: Universal Testing for Lp(a)
• Get Your Lp(a) Tested

Related MedEvidence Episodes:

• Two Heart Docs Talk Lp(a) Part 1
• Two Heart Docs Talk Lp(a) Part 2
• Two Heart Docs Talk Lp(a) Part 4
• Heart Health Research and Lp(a)
• Cholesterol, Heart Disease, Statins & Evidence-Based Medicine
• Lipoprotein the Really, Really, Really, Really Bad Cholesterol
• New Treatments for Lipoprotein(a) on the Horizon
• Lipoprotein(a) The Evil Twin of the LDL Cholesterol

Dr. Dennis Leahy is a retired interventional cardiologist living in San Diego. He received his education from Princeton University and Columbia University and his residency at the University of California. In addition to enjoying the opportunity to surf and golf, he has maintained a personal and professional interest in Lipoprotein A research and treatment.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association. 

Dr. Koren has served as an Investigator in over 2,000 trials and as the international lead investigator for many multi-centered trials including ALLIANCE, ROLE, TREAT to TARGET, OSLER, and MENDEL studies. He has written and co-authored over 100 peer-reviewed articles and been published in the most prestigious medical journals. Dr. Koren has also designed a research training course for physicians now in its 20th year. 

Original Air Date: Februar

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

Drs. Michael Koren and Dennis Leahy, cardiovascular specialists, continue with part 2 in a 4 part series of MedEvidence exploring Lipoprotein A, also know as Lp(a). Dr. Leahy shares his personal experience with Lp(a), and the duo delve into cutting-edge strategies for managing this risk factor for cardiovascular disease. So, tune in to learn more about this lesser known condition and possible treatment options.

Learn More:

• Nature Magazine, Targeting Lipoprotein(a) with siRNA
• Medscape: Universal Testing for Lp(a)
• Get Your Lp(a) Tested

Related MedEvidence Episodes:

• Two Heart Docs Talk Lp(a) Part 1
• Two Heart Docs Talk Lp(a) Part 3
• Two Heart Docs Talk Lp(a) Part 4
• Heart Health Research and Lp(a)
• Cholesterol, Heart Disease, Statins & Evidence-Based Medicine
• Lipoprotein the Really, Really, Really, Really Bad Cholesterol
• New Treatments for Lipoprotein(a) on the Horizon
• Lipoprotein(a) The Evil Twin of the LDL Cholesterol

Dr. Dennis Leahy is a retired interventional cardiologist living in San Diego. He received his education from Princeton University and Columbia University and his residency at the University of California. In addition to enjoying the opportunity to surf and golf, he has maintained a personal and professional interest in Lipoprotein A research and treatment.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association. 

Dr. Koren has served as an Investigator in over 2,000 trials and as the international lead investigator for many multi-centered trials including ALLIANCE, ROLE, TREAT to TARGET, OSLER, and MENDEL studies. He has written and co-authored over 100 peer-reviewed articles and been published in the most prestigious medical journals. Dr. Koren has also designed a resear

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

Join Drs. Michael Koren and Dennis Leahy, cardiovascular specialists, in a 4 part series of MedEvidence exploring Lipoprotein A also know as Lp(a). Dr. Leahy shares his personal experience with LP(a) and the duo delve into cutting-edge strategies for managing this risk factor for cardiovascular disease. So, tune in to learn more about this lesser known condition and possible treatment options.

Learn More:

• Nature Magazine, Targeting Lipoprotein(a) with siRNA
• Medscape: Universal Testing for Lp(a)
• Get Your Lp(a) Tested

Related MedEvidence Episodes:

• Two Heart Docs Talk Lp(a) Part 2
• Two Heart Docs Talk Lp(a) Part 3
• Two Heart Docs Talk Lp(a) Part 4
• Heart Health Research and Lp(a)
• Cholesterol, Heart Disease, Statins & Evidence-Based Medicine
• Lipoprotein the Really, Really, Really, Really Bad Cholesterol
• New Treatments for Lipoprotein(a) on the Horizon
• Lipoprotein(a) The Evil Twin of the LDL Cholesterol

Dr. Dennis Leahy is a retired interventional cardiologist living in San Diego. He received his education from Princeton University and Columbia University and his residency at the University of California. In addition to enjoying the opportunity to surf and golf, he has maintained a personal and professional interest in Lipoprotein A research and treatment.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association. 

Dr. Koren has served as an Investigator in over 2,000 trials and as the international lead investigator for many multi-centered trials including ALLIANCE, ROLE, TREAT to TARGET, OSLER, and MENDEL studies. He has written and co-authored over 100 peer-reviewed articles and been published in the most prestigious medical journals. Dr. Koren has also designed a research train

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

Tune in for an informative and insightful discussion on Heart Health and Lp(a).  Dr. Koren, a renowned cardiologist and clinical researcher, and Kevin Geddings from WSOS radio discuss the latest advancements in heart health and Lp(a).

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals.  Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.  On a personal note, Dr. Koren has a life-long interest in history, technology, Public Health, and music. He has written two musical plays.

More information and to Participate in AI Clinical Research.

Powered by ENCORE Research Group at www.ENCOREDOCS.com

#hearthealth @LP(a) #Medicine  #MedEvidence #ClinicalResearch

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

Wrapping up this month's MedEvidence! podcast series on "What to do after a Heart Attack or Stroke?"  Doctors, Michael Koren and Albert Lopez, DO discuss treatments, medications, and clinical research you need to know as a post-heart event patient.

You will learn:

• Treatment therapies to use after a heart attack or stroke
• What is Lp(a)
• Male vs Female Symptoms
• Cardiovascular Disease Research
• How to find a clinical trial

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Dr. Albert Lopez, DO practices Internal Medicine with Millennium Physician Group in Jacksonville, Florida. He is also a Principal Investigator with ENCORE Research Group specializing in lipid clinical trials. Dr. Lopez, DO completed his residency at the University of Pennsylvania and his Doctor of Osteopathic Medicine at Nova Southeastern University in Miami, Florida. He is known as one of the earliest evidence-based physicians in Jacksonville utilizing nutrition and lifestyle for disease prevention.
I believe in "N" of one" because "N of one" is about the patient. If it is not about the patient, then it is about nothing. - Dr. Albert Lopez, DO

Original Air Date: June 17, 2022

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

Dr. Michael Koren and Michelle McCormick conclude their discussion on Cholesterol and the Really, Really, Really, Really bad Cholesterol, Lp(a) in Part 4 of our 4 part series.  If you are interested in having your Lp(a) blood drawn, contact ENCORE at 904-730-0166.

Related MedEvidence Episodes:

• Cholesterol, Heart Disease, Statins & Evidence-Based Medicine
• Lipoprotein the Really, Really, Really, Really Bad Cholesterol
• New Treatments for Lipoprotein(a) on the Horizon

Learn more about Lp(a) Clinical Trials options at www.ENCOREDOCS.com

Related articles:

• On the Horizon: Treatments for Lipoprotein(a)
• Fight Inflammation to Help Prevent Heart Disease
• The Evil Twin of the LDL Cholesterol

Get your Lp(a) checked

Be a part of advancing science by participating in research

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Sponsored by ENCORE Research Group

Original Air Date: January 28, 2022

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

Dr. Michael Koren and Michelle McCormick continue their discussion on Cholesterol and the Really, Really, Really, Really bad Cholesterol, Lp(a) in Part 3 of our 4 part series. Come back next Wednesday as we wrap up our lipoprotein discussion.

Related MedEvidence Episodes:

• Cholesterol, Heart Disease, Statins & Evidence-Based Medicine
• Lipoprotein the Really, Really, Really, Really Bad Cholesterol
• Lipoprotein the Really, Really, Really, Really Bad Cholesterol

Learn more about Lp(a) Clinical Trials options at www.ENCOREDOCS.com

Related articles:

• On the Horizon: Treatments for Lipoprotein(a)
• Fight Inflammation to Help Prevent Heart Disease
• The Evil Twin of the LDL Cholesterol

Get your Lp(a) checked

Be a part of advancing science by participating in research

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Sponsored by ENCORE Research Group

Original Air Date: January 28, 2022

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

Dr. Michael Koren and Michelle McCormick continue their discussion on Cholesterol and the Really, Really, Really, Really bad Cholesterol, Lp(a) in Part 2 of our 4 part series. Come back the next two Wednesdays as we continue to dive deeper into the lipoprotein discussion.

Related MedEvidence Episodes:

• Cholesterol, Heart Disease, Statins & Evidence-Based Medicine
• New Treatments for Lipoprotein(a) on the Horizon
• Lipoprotein the Really, Really, Really, Really Bad Cholesterol

Learn more about Lp(a) Clinical Trials options at www.ENCOREDOCS.com

Related articles:

• On the Horizon: Treatments for Lipoprotein(a)
• Fight Inflammation to Help Prevent Heart Disease
• The Evil Twin of the LDL Cholesterol

Get your Lp(a) checked

Original Air Date: January 28, 2022

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

Dr. Michael Koren and Michelle McCormick discuss Cholesterol and the Really, Really, Really, Really bad Cholesterol, Lp(a) Part 1. Come back the next three Wednesdays as we continue to dive deeper into the lipoprotein discussion.

Related MedEvidence Episodes:

• Lipoprotein the Really, Really, Really, Really Bad Cholesterol
• New Treatments for Lipoprotein(a) on the Horizon
• Lipoprotein the Really, Really, Really, Really Bad Cholesterol

Learn more about Lp(a) Clinical Trials options at www.ENCOREDOCS.com

Related articles:

• On the Horizon: Treatments for Lipoprotein(a)
• Fight Inflammation to Help Prevent Heart Disease
• The Evil Twin of the LDL Cholesterol

Get your Lp(a) checked

Original Air Date: January 28, 2022

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!